Covered recipient · General Payments record
LINDSEY STEVENS BLOUNT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$1,777.90
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $291.92 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $160.91 | 12 |
| Tris Pharma Inc | $62.78 | 3 |
| Otsuka America Pharmaceutical, Inc. | $25.78 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.92 | 1 |
| ITI, Inc. | $18.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.95 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779049 | CMS |
| ABBVIE INC. | $10.90 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779053 | CMS |
| ABBVIE INC. | $11.26 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779057 | CMS |
| ABBVIE INC. | $25.76 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779061 | CMS |
| ABBVIE INC. | $13.04 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779065 | CMS |
| ABBVIE INC. | $8.88 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779069 | CMS |
| ABBVIE INC. | $13.15 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779073 | CMS |
| ABBVIE INC. | $13.96 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779077 | CMS |
| ABBVIE INC. | $5.72 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779081 | CMS |
| ABBVIE INC. | $25.76 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779085 | CMS |
| ABBVIE INC. | $11.95 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779089 | CMS |
| ABBVIE INC. | $12.58 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779093 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18.53 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143378991 | CMS |
| Otsuka America Pharmaceutical, Inc. | $25.78 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119028632 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.92 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137715229 | CMS |
| Tris Pharma Inc | $21.38 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147238035 | CMS |
| Tris Pharma Inc | $18.31 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147238033 | CMS |
| Tris Pharma Inc | $23.09 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147238037 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.